Inhibition of MicroRNA-9 Improves Fracture Healing by Modulating the Bone Morphogenetic Protein-7 Pathway

Area of Science:

• Biomedical research
• Molecular biology
• Orthopedics

Background:

• Fracture healing is a complex biological process.
• MicroRNAs (miRs) play a crucial role in regulating bone metabolism and fracture repair.
• microRNA-9 (miR-9) has been implicated in bone formation, but its specific role in fracture healing requires further investigation.

Purpose of the Study:

• To investigate the effect of inhibiting microRNA-9 (miR-9) on fracture healing in a rat model.
• To elucidate the underlying molecular mechanisms, including the involvement of the BMP-7/Runx2 signaling pathway.

Main Methods:

• A rat model of femoral fracture was established.
• Rats were divided into sham, negative control, and miR-9 inhibitor groups.
• miR-9 inhibition was achieved via intrathecal administration of an miR-9 inhibitor.
• Fracture healing was assessed by measuring bone mineral density (BMD), X-ray analysis, serum bone formation markers (osteocalcin, bone GLA protein, alkaline phosphatase), and gene/protein expression of Runx2 and BMP-7 via RT-PCR, Western blotting, and immunohistochemistry.

Main Results:

• miR-9 inhibition significantly increased BMD at the fracture site compared to controls.
• Inhibition of miR-9 promoted callus formation and reduced the fracture gap.
• Serum levels of osteocalcin and bone GLA protein increased, while alkaline phosphatase decreased following miR-9 inhibition.
• mRNA and protein levels of runt-related transcription factor 2 (Runx2) and bone morphogenetic protein 7 (BMP-7) were significantly upregulated in the miR-9 inhibitor group.

Conclusions:

• microRNA-9 (miR-9) inhibition effectively enhances fracture healing in a rat femoral fracture model.
• The pro-healing effects of miR-9 inhibition are mediated through the modulation of the BMP-7/Runx2 signaling pathway.
• Targeting miR-9 represents a potential therapeutic strategy for improving bone fracture repair.